Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Liraglutide narrows the range of circadian glycemic variations in Japanese type 2 diabetes patients and nearly flattens these variations in drug-naive type 2 diabetes patients: a continuous glucose monitoring-based study.
Mori Y, Taniguchi Y, Sezaki K, Yokoyama J, Utsunomiya K. Mori Y, et al. Among authors: taniguchi y. Diabetes Technol Ther. 2011 Nov;13(11):1139-44. doi: 10.1089/dia.2011.0137. Epub 2011 Aug 30. Diabetes Technol Ther. 2011. PMID: 21877924 Clinical Trial.
Reversible Cerebral Atrophy in Systemic Lupus Erythematosus.
Yamamoto H, Taniguchi Y. Yamamoto H, et al. Among authors: taniguchi y. Int J Rheum Dis. 2025 Jan;28(1):e70068. doi: 10.1111/1756-185X.70068. Int J Rheum Dis. 2025. PMID: 39812122 Free PMC article. No abstract available.
Stage-specific efficacy of osimertinib in treatment-naïve EGFR-mutant non-small cell lung cancer according to baseline genetic alterations in circulating tumor DNA.
Taniguchi Y, Tamiya A, Osuga M, Isa SI, Nakamura K, Mizumori Y, Shinohara T, Yanai H, Nakatomi K, Oki M, Mori M, Kuwako T, Yamazaki K, Shimada M, Ando M, Koh Y. Taniguchi Y, et al. Invest New Drugs. 2025 Jan 9. doi: 10.1007/s10637-024-01500-9. Online ahead of print. Invest New Drugs. 2025. PMID: 39789369
2,544 results